Prosecution Insights
Last updated: November 20, 2026
Application No. 19/094,429

SYSTEMS AND METHODS FOR CONTROLLED ELECTROSURGICAL COAGULATION

Non-Final OA §102§103§DOUBLEPATENT
Filed
Mar 28, 2025
Priority
Aug 10, 2023 — continuation of 12/262,936
Examiner
SHOULDERS, ANNIE LEE
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Covidien L.P.
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
1y 10m
Est. Remaining
93%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
163 granted / 218 resolved
+4.8% vs TC avg
Strong +18% interview lift
Without
With
+18.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
34 currently pending
Career history
265
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
58.1%
+18.1% vs TC avg
§102
18.9%
-21.1% vs TC avg
§112
15.8%
-24.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 218 resolved cases

Office Action

§102 §103 §DOUBLEPATENT
DETAILED ACTION Notice of Pre-AIA or AIA Status 1. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . 2. In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Claim Rejections - 35 USC § 102 3. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. 4. Claims 16-18, 23-25, and 29-31 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Yates U.S. 2015/0272657 (herein referred to as “Yates ‘657”). 5. Regarding Claim 16, Yates ‘657 teaches an electrosurgical generator (Fig. 1, ref num 120), comprising: a. a power supply configured to generate electrosurgical energy (para 0002, “Electrical energy applied by an electrosurgical instrument can be transmitted to the instrument by a generator”; para 0043, “the power generated by the generator 120”); b. an output stage configured to supply the electrosurgical energy to an electrosurgical instrument for treating tissue (Fig. 1, ref num 131; para 0035, “supply conductor 131”); c. a processor in signal communication with at least one of the power supply or the output stage (Fig. 1 or 6, ref num 125); and d. a memory having stored thereon instructions which (implicit with the control unit for controlling purposes; para 0034), when executed by the processor, cause the electrosurgical generator to: d.1 set a voltage rate of change for the electrosurgical energy (para 0035, “ the generator 120 can be configured to apply a sufficient voltage differential between the supply conductor 131 and the return conductor 133 such that sufficient current can be supplied to the end effector 126”; see Fig. 13); d.2 receive signals from the electrosurgical instrument over time indicative of a load impedance between a first electrode and a second electrode of the electrosurgical instrument (Fig. 1, ref num 164a/164b; Fig. 13; para 0096, “two impedance thresholds are utilized”); d.3 compare the load impedance with a first threshold (para 0096, “when the tissue impedance is below a first threshold”); d.4 when the load impedance is below the first threshold: set the voltage rate of change to a first rate, and deliver the electrosurgical energy while increasing a voltage of the electrosurgical energy at the first rate (Fig. 13, para 0096, “between the first threshold and the second threshold the maximum voltage of the drive signal ramps between 50 volts and 60 volts, which limits the drive signal power to 45 Watts”; Fig. 13, voltage increases below the second impedance threshold); and d.5 when the load impedance meets or exceeds the first threshold: set the voltage rate of change to a second rate, and deliver the electrosurgical energy while decreasing the voltage at the second rate (para 0096, “above the second threshold, drive signal voltage is limited to 60 Volts”; Fig. 13, voltage decreases after hitting second impedance threshold). 6. Regarding Claim 29, Yates ‘657 teaches an electrosurgical system (Fig. 1), comprising: a. an electrosurgical instrument (Fig. 1, ref num 100) having an active electrode and a return electrode (Fig. 1, ref num 164a/164b); and b. an electrosurgical generator (Fig. 1, ref num 120) configured to provide electrosurgical energy to the electrosurgical instrument for treating tissue (para 0034), the electrosurgical generator including: c. a power supply configured to generate electrosurgical energy (para 0002, “Electrical energy applied by an electrosurgical instrument can be transmitted to the instrument by a generator”; para 0043, “the power generated by the generator 120”); d. an output stage configured to supply the electrosurgical energy to an electrosurgical instrument for treating tissue (Fig. 1, ref num 131; para 0035, “supply conductor 131”); e. a processor in signal communication with at least one of the power supply or the output stage (Fig. 1 or 6, ref num 125); and f. a memory having stored thereon instructions which (implicit with the control unit for controlling purposes; para 0034), when executed by the processor, cause the electrosurgical generator to: f.1 set a voltage rate of change for the electrosurgical energy (para 0035, “ the generator 120 can be configured to apply a sufficient voltage differential between the supply conductor 131 and the return conductor 133 such that sufficient current can be supplied to the end effector 126”; see Fig. 13); f.2 receive signals from the electrosurgical instrument over time indicative of a load impedance between a first electrode and a second electrode of the electrosurgical instrument (Fig. 1, ref num 164a/164b; Fig. 13; para 0096, “two impedance thresholds are utilized”); f.3 compare the load impedance with a first threshold (para 0096, “when the tissue impedance is below a first threshold”); f.4 when the load impedance is below the first threshold: set the voltage rate of change to a first rate, and deliver the electrosurgical energy while increasing a voltage of the electrosurgical energy at the first rate (Fig. 13, para 0096, “between the first threshold and the second threshold the maximum voltage of the drive signal ramps between 50 volts and 60 volts, which limits the drive signal power to 45 Watts”; Fig. 13, voltage increases below the second impedance threshold); and f.5 when the load impedance meets or exceeds the first threshold: set the voltage rate of change to a second rate, and deliver the electrosurgical energy while decreasing the voltage at the second rate (para 0096, “above the second threshold, drive signal voltage is limited to 60 Volts”; Fig. 13, voltage decreases after hitting second impedance threshold). 7. Regarding method claim 23, the claim is rejected by the same or substantially the same rationale as applied to the rejection of apparatus claims 16 and 29, since operation of the prior art relied on to reject apparatus claims 16 and 29 would naturally result in the step of method claim 23 being satisfied. 8. Regarding Claims 17 and 30, Yates ‘657 teaches the instructions, when executed by the processor, further cause the electrosurgical generator to: determine, based on the load impedance over time, that the electrosurgical instrument is currently grasping tissue (para 0066, “When tissue is grasped by an end effector with bipolar electrodes and a full range load curve is applied, there is sometimes a short time when the tissue impedance makes a drastic change from the lower impedance to the higher impedances”); determine, based on the load impedance over time, that prior to the grasp, the electrosurgical instrument was not grasping tissue (para 0103, “jaw members 164a, 164b are in an open position without tissue between them, it may create an equivalent of an open circuit resulting in large impedance. When the electrodes then contact a subsequent tissue bite, the impedance sense by a sub-therapeutic signal is reduced. In some embodiments, the surgical system 100, 200 may detect an increase in impedance (indicating an opening of the jaws 164a,164b) followed by a decrease in impedance (indica ting a closure of jaws 164a, 164b on a new tissue bite). Impedance changes may be measured relative to any suitable references including, an impedance measured at the completion of the previous application or cycle of the tissue bite algorithm at 904”); set the voltage rate of change to an initial value defining an initial rate for coagulation without dissection of the tissue (Figs. 13-15 with different voltage slopes shown, ref nums 2000, 2010, 2020; para 0041, “energy delivery surface may be rounded to prevent the dissection of tissue”); and deliver the electrosurgical energy at the initial rate (para 0041). 9. Regarding method claim 24, the claim is rejected by the same or substantially the same rationale as applied to the rejection of apparatus claims 17 and 30, since operation of the prior art relied on to reject apparatus claims 17 and 30 would naturally result in the step of method claim 24 being satisfied. 10. Regarding Claims 18 and 31, Yates ‘657 teaches determining that the electrosurgical instrument is currently grasping tissue comprises: Comparing the load impedance over time with a second threshold, higher than the first threshold; and determining that the load impedance meets or exceeds the first threshold and is below the second threshold (para 0103, “when the jaw members 164a, 164b are in an open position without tissue between them, it may create the equivalent of an open circuit or near-open circuit, resulting in a large impedance. When the electrodes then contact a subsequent tissue bite, the impedance sensed by the sub-therapeutic signal is reduced. In some embodiments, the surgical system 100, 200 may detect an increase in impedance (indicating an opening of the jaws 164a, 164b) followed by a decrease in impedance (indicating closure of the jaws 164a, 164b on a new tissue bite). Impedance changes may be measured relative to any suitable reference including, for example, an impedance measured at the completion of the previous application or cycle of the tissue bite algorithm at 904”). 11. Regarding method claim 25, the claim is rejected by the same or substantially the same rationale as applied to the rejection of apparatus claims 18 and 31, since operation of the prior art relied on to reject apparatus claims 18 and 31 would naturally result in the step of method claim 25 being satisfied. Claim Rejections - 35 USC § 103 12. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. 13. Claims 19, 26, and 32 are rejected under 35 U.S.C. 103 as being unpatentable over Yates ‘657 and in view of Yates U.S. 2016/0270840 (herein referred to as “Yates ‘840”). 14. Regarding Claims 19 and 32, Yates ‘657 fails to teach determining that prior to the grasp, the electrosurgical instrument was not grasping tissue comprises determining that the load impedance over time decreases from a higher value that meets or exceeds the second threshold, to a lower value that meets or exceeds the first threshold and is below the second threshold. Yates ‘840 teaches an electrosurgical generator of analogous art (Fig. 1), wherein determining that prior to a grasp of the tissue, the electrosurgical instrument was not grasping tissue comprises determining that the load impedance over time decreases from a higher value that meets or exceeds the second threshold, to a lower value that meets or exceeds the first threshold and is below the second threshold (para 0128, “the generator 102, 220 may monitor an impedance between electrodes in the end effector, such as 157, 159 of the end effector 126, electrodes 177, 179 of the end effector 132, the electrodes 4177, 4179 of the end effector 4132, etc. For example, after an energy cycle, the generator 102, 220 may provide a non-therapeutic signal to the electrodes and monitor whether an open circuit is detected. An open circuit may be detected, for example, if the impedance exceeds a threshold value, if the current between the electrodes falls below a threshold value, etc. If an open circuit is detected after an energy cycle, the generator 102, 220 may determine that the end effector is no longer in contact with the tissue that was treated during the energy cycle. If no open circuit is detected after the energy cycle, the generator 102, 220 may determine that the end effector is still in contact with the tissue that was treated during the energy cycle…”). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Yates ‘657 to cause the generator to determine whether the tissue is grasped based on a load impedance, as this allows for improved efficiency of the treatment to the target tissue. 15. Regarding method claim 26, the claim is rejected by the same or substantially the same rationale as applied to the rejection of apparatus claims 19 and 32, since operation of the prior art relied on to reject apparatus claims 19 and 32 would naturally result in the step of method claim 26 being satisfied. 16. Claims 20 and 33 are rejected under 35 U.S.C. 103 as being unpatentable over Yates ‘657 and Yates ‘840, and further in view of Schulte U.S. 2013/0296908 (herein referred to as “Schulte”) and Trees U.S. 2016/0175028 (herein referred to as “Trees”). 17. Regarding Claims 20 and 33, Yates ‘657 fails to teach the first threshold is about 500 ohms to about 550 ohms, and wherein the second threshold is approximately 8,000 ohms. Schulte teaches a threshold between 500 and 550 ohms (para 0208, “the tissue impedance may be monitored to provide an indication of the completeness of the tissue cutting and/or coagulating process or to stop the activation of the ultrasonic generator 500 when the tissue impedance reaches a predetermined threshold value… the tissue impedance may range between about 10 Ohms to about 1000 Ohms from an initial point to a point just before the muscle layer is transected and sealed”). This threshold is selected to indicate that the vessel has been transected (para 0208) or other various tissue states such as sealing or dissection (para 0205). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Yates ‘657 in order to monitor the tissue state as the therapy is being applied. Trees teaches a threshold that is approximately 8000 ohms (para 0049, “threshold impedance can be greater than or equal to about 4000 ohms”). This determines whether the tissue has been captured by the electrodes and whether the tissue has been cute (para 0050). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Yates ‘657 to include the values taught by Trees for the second threshold in order to determine whether or not the tissue had been cut. 18. Claims 21, 27, and 34 are rejected under 35 U.S.C. 103 as being unpatentable over Yates ‘657 and Yates ‘840, and further in view of Schulte, Trees, and Yates U.S. 2017/0000554 (herein referred to as “Yates ‘554”). 19. Regarding Claims 21 and 34, Yates ‘657 fails to teach the first rate is approximately 180 volts per second, and the second rate is approximately 200 volts per second. Yates ‘554 teaches the voltage ramp rate set to approximately 180 volts per second and 200 volts per second as the impedance is varied below and above a threshold (para 0221, “Mode 1, the tissue impedance is low… mode 3 when the tissue impedance reaches a termination impedance”; see Fig. 47B where the voltage varies between 0-350 volts through 0-8 seconds and through various modes in which the impedance is varied). It would have been obvious to one having ordinary skill in the art at the time the invention was made to have a specific voltage ramp rate, since it has been held that discovering an optimum value of a result effective variable involves only routine skill in the art. In re Boesch, 617 F.2d 272, 205 USPQ 215 (CCPA 1980). 20. Regarding method claim 27, the claim is rejected by the same or substantially the same rationale as applied to the rejection of apparatus claims 20, 21, 33 and 34, since operation of the prior art relied on to reject apparatus claims 20, 21, 33 and 34 would naturally result in the step of method claim 27 being satisfied. Allowable Subject Matter 21. Claims 22, 28, and 35 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. 22. The following is a statement of reasons for the indication of allowable subject matter: the prior art of record fails to specifically teach setting a voltage rate of change to a third rate causing dissection of the tissue. The prior art also fails to provide sufficient motivation to make such specific modifications and would require improper use of hindsight to arrive at the claimed invention when considered along or in any proper combination. Double Patenting 23. The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). 24. A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). 25. The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. 26. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. 27. Claims 16-21, 23-27, and 29-34 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-20 of U.S. Patent No. 11,744,631. Although the claims at issue are not identical, they are not patentably distinct from each other because the claims of the reference patent anticipate the claims of the instant application. Here, the more specific patent claims encompass the broader instant application claims. For example, Claim 1 of the instant application discusses a generic system/instrument comprising a power supply, an output stage, a processor, and a memory, wherein the memory is configured to cause 1) setting a voltage rate of change for the electrosurgical energy, 2) receiving signals from the instrument over time indicative of a load impedance, 3) comparing the load impedance with a first threshold, 4) when the load impedance is below the first threshold: set the voltage rate of change to a first rate, and deliver the electrosurgical energy while increasing a voltage of the electrosurgical energy at the first rate; and 5) when the load impedance meets or exceeds the first threshold: set the voltage rate of change to a second rate, and deliver the electrosurgical energy while decreasing the voltage at the second rate, which is a broader recitation compared to the limitations outlined in the reference patent. Following the rationale in In re Goodman cited in the preceding paragraph, wherein the applicant has once been granted a patent containing a claim for the specific narrow invention, the applicant may not obtain a second patent with a claim for the generic or broader invention without first submitting an appropriate terminal disclaimer. 28. Claims 16-21, 23-27, and 29-34 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-20 of U.S. Patent No. 12,262,936. Although the claims at issue are not identical, they are not patentably distinct from each other because the claims of the reference patent anticipate the claims of the instant application. Here, the more specific patent claims encompass the broader instant application claims. For example, Claim 1 of the instant application discusses a generic system/instrument comprising a power supply, an output stage, a processor, and a memory, wherein the memory is configured to cause 1) setting a voltage rate of change for the electrosurgical energy, 2) receiving signals from the instrument over time indicative of a load impedance, 3) comparing the load impedance with a first threshold, 4) when the load impedance is below the first threshold: set the voltage rate of change to a first rate, and deliver the electrosurgical energy while increasing a voltage of the electrosurgical energy at the first rate; and 5) when the load impedance meets or exceeds the first threshold: set the voltage rate of change to a second rate, and deliver the electrosurgical energy while decreasing the voltage at the second rate, which is a broader recitation compared to the limitations outlined in the reference patent. Following the rationale in In re Goodman cited in the preceding paragraph, wherein the applicant has once been granted a patent containing a claim for the specific narrow invention, the applicant may not obtain a second patent with a claim for the generic or broader invention without first submitting an appropriate terminal disclaimer. Conclusion 29. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ANNIE L SHOULDERS whose telephone number is (571)272-3846. The examiner can normally be reached Monday-Friday (alternate Fridays) 8AM-5PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Stoklosa can be reached at 571-272-1213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ANNIE L SHOULDERS/Primary Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

Mar 28, 2025
Application Filed
Oct 22, 2026
Non-Final Rejection mailed — §102, §103, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702473
SYSTEMS FOR IMPROVING THE APPEARANCE OF TISSUE
4y 0m to grant Granted Aug 11, 2026
Patent 12702476
FORCE SENSING CATHETER INCLUDING SEALED ELECTRODE TIP ASSEMBLY AND METHODS OF ASSEMBLING SAME
2y 2m to grant Granted Aug 11, 2026
Patent 12678223
SYSTEMS AND METHODS FOR CYLINDRICAL CAGE MAPPING AND ABLATION CATHETERS HAVING FLEXIBLE CIRCUITS
2y 8m to grant Granted Jul 14, 2026
Patent 12678327
CAPSULOTOMY DEVICE
2y 7m to grant Granted Jul 14, 2026
Patent 12643111
NANO SURFACES ON SMOKE PARTICLE ELECTRODES
3y 7m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
93%
With Interview (+18.2%)
3y 6m (~1y 10m remaining)
Median Time to Grant
Low
PTA Risk
Based on 218 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month